The European surgical sutures market size was estimated at USD 1.52 billion in 2025 and is projected to be worth around USD 2.48 billion by 2035, is expanding at a CAGR of 5.00% from 2026 to 2035. The market is mainly influenced by a growing number of surgeries, an aging population, and the increasing rates of chronic diseases such as cardiovascular issues and diabetes.

Europe Surgical Sutures Market Statical Scope

The European Surgical Sutures Market is important due to high surgery volumes, an older population, and a strong need for advanced materials for wound closure in cardiovascular and orthopedic procedures. It leads in the use of biodegradable and antimicrobial sutures, supported by a strong healthcare system in countries like Germany and the UK. There is a significant uptake of innovative, bioengineered, and antimicrobial sutures that improve patient safety and clinical results.

The rising preference for minimally invasive and robotic-assisted surgeries requires precise suturing tools. Germany, France, the UK, and Italy have high healthcare expenditures, promoting investment in advanced surgical materials. There is a strong demand for biodegradable sutures that minimize tissue reaction and eliminate the need for removal.

Europe Surgical Sutures Market, By Type, 2025 (%)

• Absorbable - The absorbable segment plays a vital role in the market as it enhances patient comfort, lowers post-operative issues, and fits with the growing trend of minimally invasive techniques. These sutures, which dissolve naturally in the body after healing, hold a 61% market share because they lessen the need for removal and are more commonly used in internal surgeries.
• Non-absorbable - Non-absorbable sutures are essential in the market because they offer unmatched strength, long-lasting tissue support, and low tissue reactivity, which are necessary for high-tension and complex procedures that take a long time to heal. These sutures, made from materials that either stay in the body or need to be removed after healing, account for a 39% share and are primarily used in procedures that require long-term support.

Europe Surgical Sutures Market, By Filament, 2025 (%)

• Monofilament - The monofilament segment is important in the market due to its excellent clinical performance in lowering infection rates and tissue damage, which aligns with the region's high standards for patient safety and advancements in minimally invasive surgery. Single-strand sutures, which reduce infection risk and allow smoother tissue passage, dominate with a 54% share, reflecting the growing preference for less traumatic wound closure.
• Multifilament - The multifilament segment is significant in the market because it offers high tensile strength, excellent handling, and outstanding knot security, making it the preferred option for various complex surgical procedures. Braided sutures, which provide greater flexibility and knot security, hold a 46% share and are widely used in complex surgeries that require strong tensile strength.

Europe Surgical Sutures Market, By Application, 2025 (%)

• General Surgery - The general surgery segment plays a crucial role in the Market because of the large number of procedures, like abdominal, gastrointestinal, and hernia repairs, prompted by an aging population and increasing chronic diseases. Surgical sutures are widely used in routine abdominal and soft tissue operations, leading with a 29% market share, due to the high frequency of general surgical procedures in hospitals.
• Ophthalmic Surgery - The ophthalmic surgery segment is essential to the market due to the significant number of procedures resulting from an aging population, particularly cataract surgeries and specialized, delicate procedures such as corneal repairs. Specialized sutures are utilized in intricate eye surgeries and vision correction treatments, accounting for a 12% market share, driven by the rising demand for advanced ophthalmic care.

Competitive Landscape

• Ethicon (Johnson & Johnson) holds a leading position in the market with a wide and innovative product range and extensive distribution channels.
• Medtronic plc is a significant player that concentrates on specialized sutures, especially in cardiovascular and minimally invasive fields.
• B. Braun Melsungen AG is a well-known European manufacturer located in Germany, dedicated to high-quality suture solutions, safety, and specialized products such as antimicrobial sutures.
• Smith & Nephew plc utilizes a strong presence and network in Europe for advanced wound management and orthopedic suturing.
• Peters Surgical is an important French company that offers a variety of absorbable and non-absorbable sutures.
• Advanced Medical Solutions Group plc, based in the UK, is a leading manufacturer recognized for its innovative tissue closure solutions.
• LuxSutures is a specialized manufacturer located in Luxembourg, providing an expanding selection of sutures.
• SMI AG is a Belgian firm that produces a wide range of high-quality sutures.

Segments Covered in the Report

By Type

• Absorbable
• Non-absorbable

By Filament

• Monofilament
• Multifilament

By Application

• General Surgery
• Ophthalmic Surgery
• Cardiovascular Surgery
• Orthopedic Surgery
• Neurological Surgery
• Others